Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) is a Shell Companies company in the Financial Services sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $264M; returns 1 day -0.0%, 1 week +0.0%, 1 year +5.4%.

Drugs Made In America Acquisition Corp. (DMAA) is a Special Purpose Acquisition Company (SPAC), also known as a blank-check company, formed for the purpose of identifying and merging with a privately held entity.

DMAA financial model: income statement, cash flow and balance sheet